Abacavir-Lamivudin-Mepha 600 mg/300 mg, Filmtabletten

7680670640015 CH-67064 Filmtabletten
Abacavir-Lamivudin-Mepha 600 mg/300 mg, Filmtabletten
Abacavir-Lamivudin-Mepha 600 mg/300 mg, Filmtabletten
Abacavir-Lamivudin-Mepha 600 mg/300 mg, Filmtabletten
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/02/2024
Patient information leaflet
Français
23/02/2024
Patient information leaflet
Italien
23/02/2024
Summary of Product Characteristics
Allemand
23/02/2024
Summary of Product Characteristics
Français
23/02/2024
Summary of Product Characteristics
Italien
23/02/2024

Detailed composition

Substance Quantity Type Category
(N/A)
600.0 MG Substance Wirkstoff (Principe actif)
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
3.276 MG Substance HBESI

Reimbursement information

Public price
CHF 286.60
Specialties list
Yes
Generic
Yes
SL addition date: 01/11/2020

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
67064
Drug name
Abacavir-Lamivudin-Mepha, Filmtabletten
Galenic form
FILM
ATC Code
J05AR02
Authorization status
Z
Dispensing category
A
First authorization
04/07/2018
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
HIV-Infektion

Package details

Description (FR)
ABACAVIR LAMIVUDIN Mepha Lactab 600/300mg 30 pce
Description (DE)
ABACAVIR LAMIVUDIN Mepha Lactab 600/300mg 30 Stk
Market launch
04/07/2018
Narcotic (BTM)
No

Original drug

Kivexa, Filmtabletten
GTIN: 7680569770021
CHF 312.00
View original